Ocugen Sets March 4 Q4 Results Call; Forecasts $0.06 Loss on $1.5M Revenue
Ocugen will report Q4 and full-year 2025 results on March 4, hosting a conference call at 8:30 a.m. ET to discuss updates. Analysts forecast a $0.06 loss per share (20% wider y/y) on $1.5 million revenue, up 97.4%, after Ocugen raised $22.5 million via a January direct offering.
1. Q4 and Full-Year Results Outlook
Ocugen is scheduled to release its fourth-quarter and full-year 2025 financial results on March 4, with analysts projecting a loss of $0.06 per share—20% wider year-over-year—on revenue of $1.5 million, marking a 97.4% increase from the prior year.
2. Recent Registered Direct Offering
In January, Ocugen closed a $22.5 million underwritten registered direct offering of common stock, which initially led to a roughly 10.8% share price decline as investors absorbed potential dilution ahead of upcoming earnings.
3. Conference Call Details
The company will host an 8:30 a.m. ET conference call on March 4 to discuss quarterly results, full-year performance, and business developments, providing investors an opportunity to hear management’s commentary and outlook.